Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer

DOI: 10.1080/2162402X.2016.1139275

Keywords: Annexin A1, chemotherapy, FPR1, immunosurveillance, mammary carcinoma

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text